Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Expands By 212.4%

Abrdn Life Sciences Investors (NYSE:HQL) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 77,800 shares, a growth of 212.4% from the December 15th total of 24,900 shares. Based on an average daily trading volume, of 93,900 shares, the short-interest ratio is currently 0.8 days.

Hedge Funds Weigh In On Abrdn Life Sciences Investors

A number of hedge funds and other institutional investors have recently made changes to their positions in HQL. Future Financial Wealth Managment LLC acquired a new position in shares of Abrdn Life Sciences Investors during the 3rd quarter valued at $30,000. Ashton Thomas Securities LLC purchased a new position in shares of Abrdn Life Sciences Investors during the third quarter valued at approximately $148,000. Kapstone Financial Advisors LLC bought a new stake in shares of Abrdn Life Sciences Investors in the 3rd quarter worth $177,000. Sanctuary Advisors LLC bought a new stake in Abrdn Life Sciences Investors in the 2nd quarter worth about $154,000. Finally, Stephens Inc. AR increased its position in shares of Abrdn Life Sciences Investors by 7.6% during the third quarter. Stephens Inc. AR now owns 12,707 shares of the company’s stock valued at $192,000 after acquiring an additional 896 shares during the last quarter. 32.21% of the stock is owned by institutional investors and hedge funds.

Abrdn Life Sciences Investors Stock Up 1.5 %

Shares of Abrdn Life Sciences Investors stock opened at $13.48 on Thursday. The firm’s 50 day moving average is $13.91 and its 200 day moving average is $14.66. Abrdn Life Sciences Investors has a 1 year low of $12.76 and a 1 year high of $15.90.

Abrdn Life Sciences Investors Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Thursday, November 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 14.84%. The ex-dividend date of this dividend was Thursday, November 21st. This is a positive change from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.